Christopher Kramer MD

#cardiosky
#cardiology

#cardiosky
#cardiology

Update to the JACC Report Card: Excess Cardiovascular Mortality Among Black Americans, 2000–2023:

(2/2) Read the full Report Card & Leadership Page in #JACC:
📄 Report Card: www.jacc.org/doi/10.1016/...
📄 Leadership Page: www.jacc.org/doi/10.1016/...

#HealthEquity #Juneteenth #SDOH @msawano.bsky.social @hmkyale.bsky.social @chriskramermd.bsky.social

@cardiosky.bsky.social

@bsky.social

@bsky.social

Get to Know Your Leaders | Leading With Purpose:
Meet Chris Kramer, MD, FACC
@chriskramermd.bsky.social
#CardiologyMagazine
#CardioSky
www.acc.org/Latest-in-Ca...
@accintouch.bsky.social @jaccjournals.bsky.social @jimjanuzzi.bsky.social @drmarthagulati.bsky.social @vietheartpa.bsky.social

My Fantastic Voyage: Innovation, Mentorship, and the Future of Cardiovascular Medicine

Be resilient, take risks, and embrace change @jaccjournals.bsky.social @accintouch.bsky.social @chriskramermd.bsky.social www.jacc.org/doi/10.1016/... #cardiosky

Had the privilege of testifying before the Labor and HHS subcommittee of the House Appropriations Committee on behalf of the #ACCinTouch #AmericanCollegeofCardiology on funding of the HEARTS act (AED’s in schools) as well as for NIH and CDC funding for cardiovascular research

Podcast Episode: Unlocking Opportunities With ACC: An All-comer Guide for Early & Mid-Career Physicians | JACC: Advances In this podcast, Drs. Shelley Hall, MD, FACC and Kamala Tamirisa, MD, give practical guidance on engaging with the ACC at both the national and local levels, offering tailored strategies for early and mid-career physicians in academia and private practice to enhance their professional growth and leadership opportunities.

#EarlyCareer #ACCFIT Check out this insightful podcast 🎧 with Drs Shelley Hall & Kamala Tamirisa for valuable tips on engaging with @accintouch.bsky.social
local & national chapter!
@jaccjournals.bsky.social @csilvers.bsky.social @garimasharmamd.bsky.social

www.jacc.org/do/10.1016/2...

Congratulations to new #ACCPresident Christopher M. Kramer, MD, FACC! Inspired by a movie classic, he shared: “Today I want to talk to you about two Fantastic Voyage-Related themes: innovation and mentorship.”

💬 bit.ly/41RJlF6 @ChrisKramerMD #ACC25 #ACCLeadership

@chriskramermd.bsky.social

At #ACC25, Dr. Milton Packer & colleagues present a new secondary analysis from the #SUMMIT trial. They find tirzepatide's #heartfailure benefits extended to patients with #CKD, and that #tirzepatide also improved renal function bit.ly/4iRQJX8

#JACC #HFpEF @chriskramermd.bsky.social

I’m so proud of my great friend and colleague, Dr Katie Berlacher, who has organized an innovative and exciting @accintouch.bsky.social annual meeting.

Exciting! #STRIDE trial just presented at #ACC25 @accintouch.bsky.social . #Semaglutide improved mean walking distance, symptoms, major limb events & quality of life in patients with #T2D & #PAD. We have a new drug now to help PAD patients! #CardioSky

💡 #Semaglutide is the first therapy to ⬇️ #MACE, improve cardiometabolic and kidney outcomes and improves walking capacity, symptoms, and related #QoL in patients with #cvPAD and #T2D

#ACC25 #JACCJournals #CardioSky

Getting ready for #ACC25?

✅ Download #ACC25 app
apps.apple.com/us/app/acc-2...
✅ Follow #ACC25 ambassadors
bsky.app/profile/did:...

#CardioSky @accintouch.bsky.social @jaccjournals.bsky.social @saraersozlu.bsky.social @thornsberryjd.bsky.social @cathlabedu.bsky.social @bakhshihooman.bsky.social

New 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS Guidelines up the ante on LDL-C management for secondary ACS prevention and suggest add-on lipid lowering therapy with max tolerated statin tx – check out the update here! #CardioSky #MedSky #ClinicalGuidelines @accintouch.bsky.social

"The whole thing about gene therapy is you need to get enough gene in the right place in a site-specific manner in a safe process."

Jonathan Lindner, MD, is working to improve the safety and efficacy of gene therapies. Read more below!

#cardiology #cardiosky #medsky #genetherapy

Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity | Circulation BACKGROUND: Patients with heart failure with preserved ejection fraction and obesity have significant disability and frequent exacerbations of heart failure. We hypothesized that tirzepatide, a long-a...

Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity🔓
www.ahajournals.org/doi/10.1161/...

Coronary Calcium #CAC in Last Decade: Where Are We Now

#CardioSky #YesCCT #JACCIMG
www.jacc.org/doi/10.1016/...
@chriskramermd.bsky.social @jaccjournals.bsky.social @ljshaw.bsky.social @drdavemd.bsky.social @katehanneman.bsky.social @erinmichos.bsky.social @vietheartpa.bsky.social

New ACS Guidelines!!! www.jacc.org/doi/10.1016/... #cardiosky

Getting ready for #ACC25?
Cardiology Magazine is out

#CardioSky
www.acc.org/Membership/J...
@accintouch.bsky.social @jaccjournals.bsky.social @chriskramermd.bsky.social @a-l-bailey.bsky.social @bakhshihooman.bsky.social @vietheartpa.bsky.social @anastasiasmihaili.bsky.social @drdavemd.bsky.social

Cardiologists, patients and the entire CV community spoke—ABMS didn’t listen. We are profoundly disappointed by the decision to deny the creation of a new #CVBoard.

More: bit.ly/4ikCBoI

#CardioSky @americanheart.bsky.social @hfsa.bsky.social @scainews.bsky.social @heartrhythmsociety.bsky.social

This is such sad news.
I think we all wanted @ACCinTouch to take over our certification in #cardiology & not leave to the ABMS.
Cardiology is often a Department, not within a Division of Medicine. We need to separate to make this happen.
😢😢😢 #CardioSky

Heartfelt thanks to @accintouch.bsky.social and the #ACCCTR program for a truly transformative experience in my journey as a clinician-scientist. Feeling energized, inspired, and full of new ideas! Grateful beyond words for this fantastic program @chriskramermd.bsky.social

Deeply grateful to @accintouch.bsky.social Honored to be part of the #ACCCTR cohort—an incredibly transformative experience now coming to an end. What better way to conclude than receiving the ACC CTR grant for ‘NO-ANOCA: Inorganic Nitrate as a Treatment for ANOCA’? @chriskramermd.bsky.social

🚀 #WICMACCS2025 was a huge success! 🚀
From the inspiring keynote by Dr. Joanna Lim @BCSWIC on leadership in challenging times to powerful sessions with Dr Sandra Lewis, and more, we ignited leadership, financial empowerment for #WIC ! 💪🏽💙 @accintouch.bsky.social @chriskramermd.bsky.social

Final decision on the creation of a new cardiovascular board expected soon U.S. cardiology groups have worked together to propose the creation of a new American Board of Cardiovascular Medicine for certifying cardiologists. Now, after many months of waiting, a final decision...

Final decision expected soon on the CV community application for an independent certification board
cardiovascularbusiness.com/topics/healt... @accintouch.bsky.social @ahascience.bsky.social @hfsa.bsky.social @scainews.bsky.social @chriskramermd.bsky.social @cathiebiga.bsky.social

Our editorial today in @usatoday.com
Funding Cuts at the #NIH will harm women and set back all the gains we have made in #womenscardiovascularhealth @womensheart.bsky.social @smidtheart.bsky.social
📎 www.usatoday.com/story/opinio...